Ronald Davis
Neurology with Special Qualifications in Child Neurology · Winter Park, FLNPI 1396792024
Payments from drug & device makers
Across 652 payments — averaging $1339.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$244K
- Takeda Pharmaceuticals U.S.A., Inc.$167K
- Eisai Inc.$107K
- Eli Lilly$82K
- Zogenix Inc.$77K
- UCB, Inc.$73K
- plus $123K from 33 others
Across 4 payments — averaging $302.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$873,194 in reported general payments places this provider in the 95th percentile of 137 neurology with special qualifications in child neurology providers in Florida.
See all neurology with special qualifications in child neurology providers in Florida →
Other neurology with special qualifications in child neurology in Winter Park
- Paul WinnerWest Palm Beach$18.4M
- James RenfroeGulf Breeze$2.9M
- Walter MartinezWest Palm Beach$1.9M
- Weldon MauneyGulf Breeze$1.3M
- Ian MillerMiami$1.1M
- Jose FerreiraTampa$876K
- Peter KangGainesville$607K
- Omer Abdul HamidOrlando$467K
- Migvis MonduyMiami$455K
- Paula SchleiferMiami$394K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.